Sampada Gandhi, MD, MPH, PhD

Director, Safety Surveillance Research Scientist
Pfizer, Inc

Poster(s):

• (B-257) Preliminary Results from a European Post-Authorization Study to Assess the Safety of Paxlovid in Pregnancy
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-206) Real-World Prospective Data Assessing the Long-Term Safety of Abrocitinib Treatment in Adults with Moderate to Severe Atopic Dermatitis (AD): Over Two years of Experience from the CorEvitas AD Registry
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET